Novartis Stopping Work on Branaplam as Oral SMA Therapy & 31 Days of SMA

Novartis Stopping Work on Branaplam as Oral SMA Therapy & 31 Days of SMA

SMA News Today’s multimedia associate, Price Wooldridge, discusses Novartis stopping work on the development of Branaplam as an oral treatment for Spinal Muscular Atrophy (SMA). Forums Director Kevin Schaefer reads a story from our 31 Days of SMA series. This piece, written by Alvaro Cheherlian, is about being an entrepreneur with SMA. Link to 31 Days of SMA series: https://smanewstoday.com/category/31-days-of-sma/ Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Jaksot(444)

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
rss-pitaisko-erota
katilon-kahvitunti
puhu-muru
rss-uplevel-by-sonja-hannus
rss-rakas-mielenterveyteni
rss-narsisti
terapiassa
rss-ehjaksi
rss-duodecim-lehti
rss-vapaudu-voimaasi
selviytyjat-tarinoita-elamasta
rss-pt-paahtio
rss-eropodi
rss-mighty-finland-podcast
rss-kyykkya-ja-kuoharia